Aprea Therapeutics, Inc. (APRE)
Operating Income Growth
10.63%
TTM · Period ending:
APRE Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported10.63%period ending
Latest reported10.63%period ending
APRE TTM Operating Income YoY % (-150.61% → 10.63%)
Year-over-year change
High-resolution chart · PNG
APRE operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 10.6333% | |
| 17.547% | |
| 7.5827% | |
| 6.4445% | |
| -4.2414% | |
| -8.9751% | |
| 7.4477% | |
| -2.2139% | |
| 6.1591% | |
| 87.2666% | |
| 86.3554% | |
| 87.8142% | |
| 87.7819% | |
| -211.1663% | |
| -202.8125% | |
| -170.4525% | |
| -165.408% | |
| 30.8963% | |
| 29.0939% | |
| 13.302% | |
| -2.4002% | |
| -38.1506% | |
| -78.7526% | |
| -125.1058% | |
| -150.6102% |